Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 31% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1763.93 | 245 / 245 | 100% | 3.74 | 502 / 502 |
brain | 100% | 1316.80 | 2637 / 2642 | 100% | 5.78 | 705 / 705 |
pancreas | 100% | 1764.55 | 328 / 328 | 98% | 2.26 | 175 / 178 |
thymus | 100% | 1712.41 | 653 / 653 | 98% | 3.29 | 593 / 605 |
esophagus | 100% | 1589.43 | 1445 / 1445 | 98% | 2.71 | 179 / 183 |
lung | 100% | 1594.19 | 578 / 578 | 98% | 3.01 | 1127 / 1155 |
breast | 100% | 2290.62 | 459 / 459 | 97% | 2.98 | 1088 / 1118 |
bladder | 100% | 1957.38 | 21 / 21 | 96% | 2.58 | 485 / 504 |
stomach | 100% | 1501.09 | 359 / 359 | 95% | 2.75 | 272 / 286 |
liver | 100% | 1076.18 | 226 / 226 | 95% | 2.62 | 385 / 406 |
intestine | 100% | 1653.21 | 966 / 966 | 94% | 2.52 | 498 / 527 |
kidney | 100% | 1237.94 | 89 / 89 | 94% | 3.08 | 846 / 901 |
uterus | 100% | 1982.99 | 170 / 170 | 92% | 2.55 | 422 / 459 |
skin | 100% | 2194.03 | 1809 / 1809 | 91% | 2.37 | 429 / 472 |
ovary | 100% | 1872.43 | 180 / 180 | 89% | 2.42 | 384 / 430 |
adrenal gland | 100% | 1411.28 | 258 / 258 | 88% | 3.32 | 203 / 230 |
adipose | 100% | 2485.02 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1888.03 | 1335 / 1335 | 0% | 0 | 0 / 0 |
spleen | 100% | 1533.00 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 100% | 869.11 | 799 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 1096.27 | 838 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 1.73 | 42 / 45 |
eye | 0% | 0 | 0 / 0 | 93% | 2.66 | 74 / 80 |
lymph node | 0% | 0 | 0 / 0 | 86% | 1.68 | 25 / 29 |
peripheral blood | 56% | 593.46 | 524 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0006488 | Biological process | dolichol-linked oligosaccharide biosynthetic process |
GO_0098553 | Cellular component | lumenal side of endoplasmic reticulum membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0052918 | Molecular function | dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity |
GO_0000026 | Molecular function | alpha-1,2-mannosyltransferase activity |
GO_0052926 | Molecular function | dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity |
Gene name | ALG9 |
Protein name | Mannosyltransferase (EC 2.4.1.-) Alpha-1,2-mannosyltransferase ALG9 (EC 2.4.1.259) (EC 2.4.1.261) (Asparagine-linked glycosylation protein 9 homolog) (Disrupted in bipolar disorder protein 1) (Dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase) (Dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase) ALG9 alpha-1,2-mannosyltransferase Asparagine-linked glycosylation 9 alpha-12-mannosyltransferase-like protein isoform 1 (Asparagine-linked glycosylation 9 alpha-12-mannosyltransferase-like protein isoform 2) |
Synonyms | DIBD1 |
Description | FUNCTION: Catalyzes the transfer of mannose from Dol-P-Man to lipid-linked oligosaccharides. . |
Accessions | A0A087WTZ3 ENST00000616540.5 [Q9H6U8-3] H0YCW6 ENST00000619129.4 A0A087WX16 A0A087WZY8 ENST00000618252.1 ENST00000531154.5 [Q9H6U8-4] H0YF48 ENST00000614444.4 [Q9H6U8-1] A0A087WVC0 H0YEX8 Q9H6U8 ENST00000612489.1 ENST00000524671.1 ENST00000398006.6 [Q9H6U8-2] ENST00000613181.4 ENST00000532425.6 A0A0S2Z5N6 ENST00000525910.1 |